Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration


Journal article


Michael R. Duggan, Zhijian Yang, Yuhan Cui, H. E. Dark, Junhao Wen, G. Erus, T. Hohman, Jingsha Chen, Alexandria Lewis, A. Moghekar, J. Coresh, Susan M. Resnick, C. Davatzikos, Keenan A. Walker
Alzheimer's & Dementia, 2024

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Duggan, M. R., Yang, Z., Cui, Y., Dark, H. E., Wen, J., Erus, G., … Walker, K. A. (2024). Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration. Alzheimer's &Amp; Dementia.


Chicago/Turabian   Click to copy
Duggan, Michael R., Zhijian Yang, Yuhan Cui, H. E. Dark, Junhao Wen, G. Erus, T. Hohman, et al. “Proteomic Analyses Reveal Plasma EFEMP1 and CXCL12 as Biomarkers and Determinants of Neurodegeneration.” Alzheimer's & Dementia (2024).


MLA   Click to copy
Duggan, Michael R., et al. “Proteomic Analyses Reveal Plasma EFEMP1 and CXCL12 as Biomarkers and Determinants of Neurodegeneration.” Alzheimer's &Amp; Dementia, 2024.


BibTeX   Click to copy

@article{michael2024a,
  title = {Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration},
  year = {2024},
  journal = {Alzheimer's & Dementia},
  author = {Duggan, Michael R. and Yang, Zhijian and Cui, Yuhan and Dark, H. E. and Wen, Junhao and Erus, G. and Hohman, T. and Chen, Jingsha and Lewis, Alexandria and Moghekar, A. and Coresh, J. and Resnick, Susan M. and Davatzikos, C. and Walker, Keenan A.}
}

Abstract

Plasma proteomic analyses of unique brain atrophy patterns may illuminate peripheral drivers of neurodegeneration and identify novel biomarkers for predicting clinically relevant outcomes.



Tools
Translate to